Geoff Meacham
Stock Analyst at Citi
(4.85)
# 397
Out of 4,994 analysts
1203
Total ratings
58.3%
Success rate
15.7%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintained: Hold | $405 | $376.35 | +7.61% | 48 | Sep 22, 2026 | |
| ABOS Acumen Pharmaceuticals | Reiterated: Buy | $4 → $5 | $2.61 | +91.57% | 12 | Sep 15, 2026 | |
| MANE Veradermics | Reiterated: Buy | $160 | $102.42 | +56.22% | 11 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $60 → $74 | $49.37 | +49.89% | 7 | Sep 14, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $182 | $142.84 | +27.42% | 14 | Sep 9, 2026 | |
| RPRX Royalty Pharma | Reiterated: Buy | $70 | $58.47 | +19.72% | 28 | Sep 9, 2026 | |
| VOR Vor Biopharma | Reiterated: Buy | $50 | $21.95 | +127.79% | 4 | Sep 9, 2026 | |
| ABBV AbbVie | Reiterated: Hold | $260 | $262.51 | -0.96% | 67 | Sep 4, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $585 | $513.26 | +13.98% | 67 | Sep 2, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,600 | $1,137.82 | +40.62% | 100 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $95.83 | +30.44% | 17 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $32 | $32.63 | -1.93% | 21 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $145.62 | -58.80% | 62 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $63.60 | +10.06% | 73 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $135 | $116.33 | +16.05% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $27.46 | - | 75 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $147.68 | +11.73% | 81 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $200 → $215 | $216.01 | -0.47% | 73 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $700 → $740 | $774.61 | -4.47% | 60 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $100 | $77.62 | +28.83% | 18 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $34.24 | +60.63% | 3 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $125 | $144.91 | -13.74% | 64 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $9.35 | -25.13% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 | $67.59 | +10.96% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $21.18 | +159.68% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 | $267.28 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.7732 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $64.73 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $1.25 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $52.21 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $9 | $10.78 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $27.54 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $2.92 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $58.77 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.756 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $24.35 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $50.29 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.86 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $10.52 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $16.25 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $68.45 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $68.30 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $24.65 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $4.14 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $2.71 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $498.48 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $69.39 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $1.15 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $17.34 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.43 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $20 | $15.36 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $7.98 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49 → $75 | $8.24 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $0.8999 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $32.55 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $3.48 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $8.43 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $24.53 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.1476 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $10.98 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $63.48 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €78.04 | €131.70 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $10.96 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $124.75 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $13 | $4.17 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.93 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $11.89 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $110 | $149.50 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $2.77 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42.89 | $7.98 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $239.36 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $26.24 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $12.70 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $32.95 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.15 | n/a | 1 | Sep 17, 2012 |
Amgen
Sep 22, 2026
Maintained: Hold
Price Target: $405
Current: $376.35
Upside: +7.61%
Acumen Pharmaceuticals
Sep 15, 2026
Reiterated: Buy
Price Target: $4 → $5
Current: $2.61
Upside: +91.57%
Veradermics
Sep 15, 2026
Reiterated: Buy
Price Target: $160
Current: $102.42
Upside: +56.22%
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $74
Current: $49.37
Upside: +49.89%
Protagonist Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $182
Current: $142.84
Upside: +27.42%
Royalty Pharma
Sep 9, 2026
Reiterated: Buy
Price Target: $70
Current: $58.47
Upside: +19.72%
Vor Biopharma
Sep 9, 2026
Reiterated: Buy
Price Target: $50
Current: $21.95
Upside: +127.79%
AbbVie
Sep 4, 2026
Reiterated: Hold
Price Target: $260
Current: $262.51
Upside: -0.96%
Vertex Pharmaceuticals
Sep 2, 2026
Reiterated: Buy
Price Target: $585
Current: $513.26
Upside: +13.98%
Eli Lilly and Company
Sep 1, 2026
Reiterated: Buy
Price Target: $1,600
Current: $1,137.82
Upside: +40.62%
Aug 31, 2026
Reiterated: Buy
Price Target: $125
Current: $95.83
Upside: +30.44%
Aug 19, 2026
Reiterated: Buy
Price Target: $26 → $32
Current: $32.63
Upside: -1.93%
Aug 19, 2026
Reiterated: Hold
Price Target: $60
Current: $145.62
Upside: -58.80%
Aug 14, 2026
Reiterated: Hold
Price Target: $70
Current: $63.60
Upside: +10.06%
Aug 6, 2026
Reiterated: Buy
Price Target: $120 → $135
Current: $116.33
Upside: +16.05%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $27.46
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: $165
Current: $147.68
Upside: +11.73%
Aug 3, 2026
Reiterated: Hold
Price Target: $200 → $215
Current: $216.01
Upside: -0.47%
Aug 3, 2026
Reiterated: Hold
Price Target: $700 → $740
Current: $774.61
Upside: -4.47%
Jul 29, 2026
Reiterated: Buy
Price Target: $60 → $100
Current: $77.62
Upside: +28.83%
Jul 16, 2026
Reiterated: Buy
Price Target: $55
Current: $34.24
Upside: +60.63%
Jul 15, 2026
Reiterated: Hold
Price Target: $125
Current: $144.91
Upside: -13.74%
May 7, 2026
Reiterated: Sell
Price Target: $7
Current: $9.35
Upside: -25.13%
May 7, 2026
Reiterated: Hold
Price Target: $75
Current: $67.59
Upside: +10.96%
Jan 30, 2026
Reiterated: Buy
Price Target: $55
Current: $21.18
Upside: +159.68%
Jun 10, 2024
Reiterated: Hold
Price Target: $170
Current: $267.28
Upside: n/a
Jun 6, 2024
Reiterated: Buy
Price Target: $22
Current: $0.7732
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $130
Current: $64.73
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $1.25
Upside: n/a
May 23, 2024
Reiterated: Buy
Price Target: $100
Current: $52.21
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $14 → $9
Current: $10.78
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $36
Current: $27.54
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $2.92
Upside: n/a
May 10, 2024
Reiterated: Buy
Price Target: $101
Current: $58.77
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.756
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $24.35
Upside: n/a
Oct 11, 2023
Reiterated: Sell
Price Target: n/a
Current: $50.29
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $1.86
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $10.52
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $16.25
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $68.45
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $68.30
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $24.65
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $4.14
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $2.71
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $498.48
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $69.39
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $1.15
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $17.34
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.43
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $28 → $20
Current: $15.36
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $7.98
Upside: n/a
Oct 8, 2021
Reiterated: Hold
Price Target: $49 → $75
Current: $8.24
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $0.8999
Upside: n/a
Mar 19, 2021
Reiterated: Buy
Price Target: $35
Current: $32.55
Upside: n/a
Jan 5, 2021
Reiterated: Buy
Price Target: $70
Current: $3.48
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $8.43
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $24.53
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.1476
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $10.98
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $63.48
Upside: n/a
Feb 20, 2020
Reiterated: Hold
Price Target: €78.04
Current: €131.70
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $10.96
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $124.75
Upside: n/a
May 2, 2019
Reiterated: Hold
Price Target: $13 → $13
Current: $4.17
Upside: n/a
Mar 29, 2019
Reiterated: Buy
Price Target: $27
Current: $1.93
Upside: n/a
Mar 29, 2019
Reiterated: Hold
Price Target: $8
Current: $11.89
Upside: n/a
Mar 28, 2019
Reiterated: Buy
Price Target: $103 → $110
Current: $149.50
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $2.77
Upside: n/a
Feb 20, 2019
Rated: Buy
Price Target: $42.89
Current: $7.98
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $239.36
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $26.24
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $12.70
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $32.95
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $12.15
Upside: n/a